Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06047353 · ClinicalTrials.gov registry record · NA

Community Health Advocates for Motivating PAP Use in Our Neighborhoods.

A NA study of Obstructive Sleep Apnea, sponsored by University of Miami.

Recruiting
Registry status
NA
Development phase
48
Enrollment target
1
Study location

NCT06047353 is a NA study of Obstructive Sleep Apnea that is actively recruiting participants, run by University of Miami. The registered enrollment target is 48 participants, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06047353, a NA study of Obstructive Sleep Apnea, is actively recruiting participants, sponsored by University of Miami.

RECRUITING
Registry status
NA
Development phase
48 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to compare the impact of motivational enhancement therapy (MET), delivered by culturally congruent community health care workers (CHWs) versus usual care patients with previously untreated moderate-to-severe obstructive sleep apnea (OSA) on adherence to positive airway pressure (PAP) therapy.

Conditions Studied

Interventions

  • BEHAVIORAL Motivational Enhancement Therapy
  • DEVICE Positive Airway Pressure (PAP) therapy

Study Locations (1)

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2023-09-29
Est. Completion 2027-12-31
Phase NA

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT06047353

The ClinicalTrials.gov registry entry for NCT06047353 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (78% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 2 interventions - of which Motivational Enhancement Therapy is the first listed.

NCT06047353 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06047353 about?

NCT06047353 is a clinical study titled "Community Health Advocates for Motivating PAP Use in Our Neighborhoods.". The purpose of this research is to compare the impact of motivational enhancement therapy (MET), delivered by culturally congruent community health care workers (CHWs) versus usual care patients with previously untreated moderate-to-severe obstructive sleep apnea (OSA) on adherence to positive airwa...

What is the current status of trial NCT06047353?

This trial is currently recruiting. It is a NA study. The enrollment target is 48 participants. The study started on 2023-09-29. Estimated completion is 2027-12-31.

What conditions does trial NCT06047353 study?

This clinical trial studies the following conditions: Obstructive Sleep Apnea.

What interventions are being tested in trial NCT06047353?

The interventions under investigation include: Motivational Enhancement Therapy (BEHAVIORAL), Positive Airway Pressure (PAP) therapy (DEVICE).

Who is sponsoring clinical trial NCT06047353?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06047353 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obstructive Sleep Apnea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.